Aspects of communication in Alzheimer's disease: clinical features and treatment options

Grants

Funding Acknowledgements

Michael Woodward has received speaker honoraria and payment for Advisory Board activities from H. Lundbeck A/S, Novartis, Pfizer, Nutricia, and Johnson and Johnson (Janssen Cilag). There are no other conflicts of interest relevant to this paper. The sponsor, H. Lundbeck A/S, provided funding for editorial assistance during the writing of this paper.